insights_auto
Why is ONCY down 8,63%?
Dive Deeperchevron_right
ONCY:NASDAQ
Oncolytics Biotech Inc
0,54 US$
arrow_downward
-8,63%(-0,051) 1D
0,55 US$
arrow_upward
+1,03% (+0,0056)bedtimeAfter hours
Closed: 8 ოქტ, 16:00:00 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ONCY...
Open
0,60 US$
High
0,61 US$
Low
0,54 US$
Mkt. cap
70,88 მლნ.
Avg. vol.
1,02 მლნ.
Volume
1,12 მლნ.
52-wk high
1,32 US$
52-wk low
0,54 US$
Beta
1,15
Shares outstanding
127,51 მლნ.
No. of employees
29
Open
0,60 US$
High
0,61 US$
Low
0,54 US$
Mkt. cap
70,88 მლნ.
Avg. vol.
1,02 მლნ.
Volume
1,12 მლნ.
52-wk high
1,32 US$
52-wk low
0,54 US$
Beta
1,15
Shares outstanding
127,51 მლნ.
No. of employees
29
News stories
From web sources and news partners
Yahoo Finance
·
13 წუთის წინ
Bending Spoons (NasdaqGS:BSP) Taps Credit Markets Again As Its Undervalued Narrative Gets Tested
The Dark Side Of The Boom
·
46 წუთის წინ
The S&P 500 Is Still Standing but the Foundations Are Starting to Crack
CNBC
·
3 საათის წინ
Tokenization could unleash tens of billions of dollars in trapped capital, Nasdaq CEO says
Bloomberg.com
·
5 საათის წინ
Tech Stocks to Fall as OpenAI Sinks US Chipmakers: Markets Wrap
Profile
Oncolytics Biotech Inc. is a biotech company headquartered in San Diego, California, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses. Wikipedia
About Oncolytics Biotech Inc